Selective cyclooxygenase-1 (COX-1) inhibition has got into the spotlight with the discovery of COX-1 upregulation in various cancers and the cardioprotective role of COX-1 in control of thrombocyte aggregation. Yet, COX-1-selective inhibitors are poorly explored. Thus, three series of quinazoline derivatives were prepared and tested for their potential inhibitory activity toward COX-1 and COX-2. Of the prepared compounds, 11 exhibited interesting COX-1 selectivity, with 8 compounds being totally COX-1-selective. The IC50 value of the best quinazoline inhibitor was 64 nM. The structural features ensuring COX-1 selectivity were elucidated using in silico modeling.

Department of Pharmaceutical and Medicinal Chemistry Paracelsus Medical University of Salzburg Strubergasse 21 5020 Salzburg Austria

Laboratory of Plant Biotechnologies Czech Academy of Sciences Institute of Experimental Botany Rozvojova 263 165 02 Prague 6 Lysolaje Czech Republic

Citace poskytuje Crossref.org